Fenómenos trombóticos por COVID-19.

Palabras clave: Hipercoagulabilidad, COVID-19, Dímero-D, Coagulación, Profilaxis

Resumen

Respecto al artículo el artículo “Hipercoagulabilidad asociada a COVID-19, acercamiento clínico” publicado en el suplemento sobre COVID-19 y Sars-CoV-2 de la Revista Salutem Scientia Spiritus, esta carta al editor `pretende resaltar la importancia de identificar signos, manejo anticoagulante previo y parámetros de laboratorio asociados a complicaciones tromboembólicas, específicamente el uso del dímero D, el cual resulta valioso en un contexto en el que se estima que los episodios trombóticos venosos rondan el 8% en todos los pacientes con COVID-19 y hasta el 69% en los pacientes críticos. En este sentido, la búsqueda de herramientas que acerquen a una perspectiva de hipercoagulabilidad son las que permitirán una anticoagulación preventiva más eficaz.

Abstract:

Regarding the article “Hypercoagulability associated with COVID-19, clinical approach” published in the supplement of COVID-19 and Sars-CoV-2 of the Salutem Scientia Spiritus Journal, this letter to the editor intends to highlight the importance of identifying signs, anticoagulant management background and laboratory parameters associated with thromboembolic complications, specifically the use of D-dimer, which is valuable in a context in which it is estimated that venous thrombotic episodes are around 8% in all patients with COVID-19 and up to 69 % in critical patients. In this sense, the search for tools that bring a hypercoagulable perspective closer are those that will allow a more effective preventive anticoagulation.

Key words: Hypercoagulability, COVID-19, D-dimer, blood coagulation, prophylaxis.

Biografía del autor/a

Mario Alonso Arotuma, Programa de Estudios de Medicina Humana Universidad Privada San Juan Bautista (Perú)

Estudiante de medicina

Citas

Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H. 2021 undefined. COVID 19 and ischemic stroke: Mechanisms of hypercoagulability. spandidos-publications. 2021; 47(3).

Wen Tan C, Yuan Tan J, Hui Wong W, Anne Cheong M, Matthias Ng I, Philip Conceicao E et al. Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and other. Sci Reports. 2021; 11(1):1793. DOI: 10.1038/s41598-021-81166-y

Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B et al. Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections? Preliminary data. Chirurg. 2020; 588-94.

Moreno G, Carbonell R, Bodí M, Rodríguez A. Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients. Med Intensiva. 2021; 45(1):42-55. DOI: 10.1016/j.medine.2020.06.006

Publicado
2021-06-23
Cómo citar
Arotuma, M. (2021). Fenómenos trombóticos por COVID-19. Salutem Scientia Spiritus, 7(2), 14-15. Recuperado a partir de https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/2565